Target intelligence / Profile preview

RNA, U6 small nuclear 1290, pseudogene (RNU6-1290P)

Target
RNU6-1290P
Molecular classification
Other (Pseudogene; Small nuclear RNA-derived pseudogene)
01

Overview

RNU6-1290P is a processed pseudogene derived from U6 small nuclear RNA (U6 snRNA)[5]. U6 snRNA is an essential RNA component of the spliceosome, a ribonucleoprotein complex that catalyzes the removal of introns from precursor mRNA through splicing in eukaryotic nuclei[1][3]. Pseudogenes like RNU6-1290P are formed by retrotransposition or other genome rearrangements but do not encode functional RNAs or proteins and are not typically transcribed or translated[5]. The U6 snRNA gene family is highly conserved and vital for RNA splicing, but pseudogenes arising from U6 snRNA do not participate in splicing or other cellular functions[5][3]. RNU6-1290P merely reflects the evolutionary and genomic dynamics of U6-related sequences and has no therapeutic relevance or functional activity. - Note: There is no evidence of "RNU6-1290P" directly functioning as an RNA, being a gene product, protein, or drug target. Its classification as a pseudogene excludes it from most biomedical or pharmacological ontologies as a relevant therapeutic or diagnostic target[5]. If you require structured information for a functional U6 small nuclear RNA or its canonical gene (not a pseudogene), additional information about "U6 snRNA" or its true genomic loci would be appropriate.

Other names
RNU6-1290P

Beyond the preview

Go deeper on RNA, U6 small nuclear 1290, pseudogene (RNU6-1290P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1290, pseudogene (RNU6-1290P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call